scispace - formally typeset
G

Giannoula S. Tansarli

Researcher at Brown University

Publications -  51
Citations -  2675

Giannoula S. Tansarli is an academic researcher from Brown University. The author has contributed to research in topics: Tigecycline & Medicine. The author has an hindex of 23, co-authored 47 publications receiving 2217 citations. Previous affiliations of Giannoula S. Tansarli include American Institute of Biological Sciences & ALFA.

Papers
More filters
Journal ArticleDOI

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.

TL;DR: In 7 studies, mortality rates ranged from 26% to 44%; in 2 studies, rates were −3% and −4%, respectively.
Journal ArticleDOI

Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence

TL;DR: Evaluating the effectiveness of the antibiotic treatment administered for infections caused by carbapenemase-producing Enterobacteriaceae found that combination antibiotic treatment may be considered the optimal option for severely ill patients with severe infections.
Journal ArticleDOI

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis

TL;DR: Based on data from non-randomized studies, carbapenems may be considered the treatment of choice for empirical treatment of patients with ESBL-producing Enterobacteriaceae bacteraemia.
Journal ArticleDOI

Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis

TL;DR: The available evidence from mainly nonrandomized studies suggests that extended or continuous infusion of carbapenems or piperacillin/tazobactam was associated with lower mortality.
Journal ArticleDOI

Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis.

TL;DR: The currently available literature suggests that the ME panel has high diagnostic accuracy, however, the decision for implementation should be individualized based on the needs of the patient population, the capabilities of the laboratory, and the knowledge of the healthcare providers that will utilize the test.